/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Risk of upper gastrointestinal bleeding following myocardial infarction: a novel prediction model for assessing appropriateness of proton pump inhibition therapy
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: New applications of risk assessment in coronary artery disease
Continuing decline in incidence of recurrent myocardial infarction, stroke, and death following first myocardial infarction: a 15-year nationwide cohort study
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Management of coronary disease: temporal trends and residual risk
Cost-effectiveness of canakinumab to prevent recurrent cardiovascular events
Event: ESC Congress 2018
Topic: Health Economics
Session: Health economics
Dose-response relationship between proton pump inhibitor use and associated risk of myocardial infarction: a nationwide cohort study
Event: ESC Congress 2016
Topic: Drug therapy
Session: Lipid-lowering agents - New perspectives
ESC 365 is supported by
